Vetter, a Contract Development and Manufacturing Organisation (CDMO), continues to expand its commercial fill-and-finish network to further strengthen its global manufacturing operations and support the evolving needs of pharma and biotech customers.
ChargePoint Technology has announced the launch of ChargePoint Actis, an aseptic transfer system set to change how pharmaceutical manufacturers achieve sterility assurance at one of the most critical risk points of aseptic processes.
Upperton has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved a variation to its existing Manufacturing and Importation Authorisation for Investigational Medicinal Products (MIA(IMP)) licence.
Steriline is enhancing and strengthening the use of AI in its solutions, and is introducing two intelligent technologies that work in synergy: OmniAI Vision and OptiLAIN.
Théa and Unither Pharmaceuticals announce the signing of a long-term strategic industrial partnership aimed at supporting Théa Group’s growth in Europe.
Christian Dunne, director of global corporate business development, ChargePoint Technology explores a risk-based response to evolving Annex 1 expectations.
Shantha Biologics has announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
In applications where accuracy and sterility are non negotiable, BellatRx relies on a Flexicon PF7+ peristaltic filling machine as part of its Aquarius Monobloc solution.
In aseptic manufacturing, the most significant risk has never been the equipment itself. The most quantitatively significant risk has been the people working in the classified environment in which the equipment is installed.
Shibuya Corporation has developed and refined its Hydrogen Peroxide Vapor Decontamination System (HPVD) over more than two decades to support advanced aseptic manufacturing and packaging environments.
